目的:探讨益生菌联合营养支持对胃肠外科术后患者肠功能和肠道菌群的影响。方法:36例胃肠道中等以上手术的患者,随机分为研究组和对照组,每组18例。两组术后均接受等氮等能量的营养支持,研究组患者于术后第3天开始每天加用益生菌制剂(6.6 × 10.7 colony forming units),共7天。监测治疗期间患者的胃肠道症状、生命体征、腹泻情况和菌群比例等。结果:两组患者术后腹痛、腹胀、肠鸣音异常等胃肠道症状均无显著差异 (P gt;0.05),两组患者在术后第8和9天的腹泻比例和腹泻评分差异有显著性意义(P lt;0.05)。治疗结束后,研究组患者肠道双歧杆菌和乳酸杆菌计数均较对照组高,两组间差异有显著性意义(P lt;0.05)。 结论:在胃肠外科术后患者中应用益生菌可改善胃肠道症状、减轻腹泻程度和纠正肠道菌群失调。
Citation：
LI Shuqing,WU Denggui.. Application of Probiotics with Nutrition Support in Patients after Gastrointestinal Surgery. West China Medical Journal, 2009, 24(10): 2538-2539. doi:
Copy
Copyright © the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved
| 1. |
DEITCH E A. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings[J]? Surgery, 2002, 131: 241244.
|
| 2. |
JAIN P K, MCNAUGHT C E, ANDERSON A D, et al. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial[J]. Clin Nutr, 2004, 23:467-475.
|
| 3. |
HART G K, DOBB G J. Effect of a fecal bulking agent on diarrhea during enteral feeding in the critically ill [J]. JPEN, 1988, 12 (5): 465-468.
|
| 4. |
LILLY D M, STILLWELL R H. Probiotics: growthpromoting factors produced by microorganisms[J]. Science, 1965, 147:747-748.
|
| 5. |
LAUDANNO O M, CESOLARI J A, GODOY A, et al. Bioflora probiotic in immunomodulation and prophylaxis of intestinal bacterial translocation in rats[J]. Dig Dis Sci, 2008, 53:2667-2670.
|
| 6. |
RAFTER J, BENNETT M, CADERNI G, et al.Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients[J]. Am J Clin Nutr, 2007, 85:488-496.
|
| 7. |
ANDERSON A D, MCNAUGHT C E, JAIN P K, et al. Randomised clinical trial of synbiotic therapy in elective surgical patients[J]. Gut, 2004,53:241-245.
|
- 1. DEITCH E A. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings[J]? Surgery, 2002, 131: 241244.
- 2. JAIN P K, MCNAUGHT C E, ANDERSON A D, et al. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial[J]. Clin Nutr, 2004, 23:467-475.
- 3. HART G K, DOBB G J. Effect of a fecal bulking agent on diarrhea during enteral feeding in the critically ill [J]. JPEN, 1988, 12 (5): 465-468.
- 4. LILLY D M, STILLWELL R H. Probiotics: growthpromoting factors produced by microorganisms[J]. Science, 1965, 147:747-748.
- 5. LAUDANNO O M, CESOLARI J A, GODOY A, et al. Bioflora probiotic in immunomodulation and prophylaxis of intestinal bacterial translocation in rats[J]. Dig Dis Sci, 2008, 53:2667-2670.
- 6. RAFTER J, BENNETT M, CADERNI G, et al.Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients[J]. Am J Clin Nutr, 2007, 85:488-496.
- 7. ANDERSON A D, MCNAUGHT C E, JAIN P K, et al. Randomised clinical trial of synbiotic therapy in elective surgical patients[J]. Gut, 2004,53:241-245.
